Atenolol

Therapeutic indications

Atenolol is indicated for:

Myocardial infarction

Population group: both men and women, only adults (18 years old or older)

Atenolol is indicated for the management of myocardial infarction for early intervention in the acute phase.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypertension

Population group: both men and women, only adults (18 years old or older)

Atenolol is indicated in the treatment of management of hypertension.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Angina pectoris

Population group: both men and women, only adults (18 years old or older)

Atenolol is indicated in the treatment of management of angina pectoris.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Cardiac arrhythmias

Population group: both men and women, only adults (18 years old or older)

Cardiac arrhythmia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Atenolol is contraindicated in the following cases:

Cardiogenic shock

Cardiogenic shock

Uncontrolled heart failure

Decompensated cardiac failure

Sick sinus syndrome

Sick sinus syndrome

Second, third-degree heart block

at least one of
Second degree atrioventricular block
Complete atrioventricular block

Untreated phaeochromocytoma

Phaeochromocytoma

Metabolic acidosis

Metabolic acidosis

Bradycardia (<45 bpm)

Bradycardia

Hypotension

Hypotension

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: TENORMIN Tablets
Summary of Product Characteristics (SPC) 2017: TENORMIN Solution for injection
< Previous: Overview
Next: Precautions >